Jounce Therapeutics, Inc. (JNCE) is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial.
Jounce seeks an experienced corporate and securities counsel to join its Legal Department reporting directly to the Senior Vice President of Legal. This newly created position offers the opportunity to become a key member of the Jounce legal team, working in a fast-paced, high energy environment, where initiative, creative thinking and collaboration are valued.
To apply, please visit https://careers-jouncetx.icims.com